Sexual function in women with hypothalamo-pituitary disorders
- 68 Downloads
The extent to which hypothalamo-pituitary disorders in women affect sexual desire and sexual functions was investigated. Sexual functions and sexual appreciation were assessed in a comprehensive interview of 48 women with well-defined hypothalamo-pituitary disorders. Data about sex life were correlated to blood hormone levels and diagnosis. In most of the women (64.8%), the first clinical symptom indicating a hypothalamo-pituitary dysfunction began in the age group 16 to 35. In 43 patients (89.6%), the initial symptom was menstrual irregularities. Altogether 45 (93.8%) of the women declared that they had or had had significant sexual problems. Two of the three women who did not report sexual problems had never had intercourse. Thirty-eight (79.2%) of the women had developed a lack of or a considerable decrease in sexual desire. Problems with lubrication or orgasm were reported by 31 (64.6%) and 33 (68.7%) of the women, respectively. Normal menstrual pattern, young age, and intrasellar tumor growth correlated better with normal sexual desire and sexual functions than did normal prolactin levels and normal testosterone levels. However, at the time of interview, only 7 women had hyperprolactinemia. Serum testosterone values correlated significantly only with masturbation.
Key wordsfemale sexuality menstruation hypothalamo-pituitary disorders testosterone prolactin
Unable to display preview. Download preview PDF.
- Batzdorf, U., and Stern, W. E. (1973). Clinical manifestations of pituitary adenomas: A pilot study using computer analysis. In Koler, P. O., and Ross, G. T. (eds.),Pituitary Tumors Exerpta Medica, Amsterdam, p. 17.Google Scholar
- Campbell, S., and Whitehead, M. (1977). Oestrogen therapy and the menopausal syndrome.Clin. Obstet. Gynecol. 4: 31–47.Google Scholar
- Coope, J. J. (1976). Double blind cross-over study of estrogen replacement therapy. In Campbell, S. (ed.),The Management of the Menopause and Post-Menopausal Years University Park Press, Baltimore, pp. 159–168.Google Scholar
- Fischer, P-A. (1963).Hypophysenadenome Ferdinand Enke Verlag, Stuttgart.Google Scholar
- Franks, S., Jacobs., H. S., Martin, N., and Nabarro, J. D. N. (1978). Hyperprolactinemia and impotence.Clin. Endocrinol. 8: 277–287.Google Scholar
- Heimbach, S. B. (1959). Follow-up studies on 105 cases of verified chromophobe and acidophile pituitary adenomata after treatment by transfrontal operation and x-ray irradiation.Acta Neurochir. 7: 101–155.Google Scholar
- Lundberg, P. O., Muhr, C., Hulter, B., Brattberg, A., and Wide, L. (1986). Sexual libido in patients with hypothalamopituitary disorders. In Kothari, P. (ed.),Proceedings of the 7th World Congress of Sexology, New Delhi, pp. 126–128.Google Scholar
- Muhr, C., Hulting, A-L., Lundberg, P. O., and Werner, S. (1985). Pituitary adenomas with hyperprolactinemia in males. In Auer, L. M., Leb, L. G., Tscherne, G., Urdl, W., and Walter, G. F. (eds.),Prolactinomas. An Interdisciplinary Approach de Gruyter, New York, pp. 169–178.Google Scholar
- Nagulesparen, M., Ang, V., and Jenkins, J. S. (1978). Bromocriptine treatment of males with pituitary tumours, hyperprolactinemia, and hypogonadism.Clin. Endocrinol. 9: 73–79.Google Scholar
- Roeder, F., Müller, D., and Orthner, H. (1971). Weitere Erfahrungen mit der stereotaktischen Behandlung sexueller Perversionen.J. Neuro-Visceral Rel. Suppl. 10: 317–324.Google Scholar
- Wide, L. (1969). Radioimmunoassays employing immunosorbents.Acta Endocrinol. 142 (Suppl.): 207–221.Google Scholar